ALFA Filings
Every announcement, straight from the exchange
Every Astec Lifesciences other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
7 announcements
Astec LifeSciences filed a Reg 54 Nil Security Cover certificate for its listed unsecured NCDs, stating the security cover format is not applicable. This is routine compliance paperwork with no new money or business event.
Astec Lifesciences Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements.
Astec Lifesciences filed a compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, for the quarter ended September 30, 2026, confirming no rematerialization requests received.
Astec LifeSciences confirmed nil deviation in the utilization of proceeds from its listed Non-Convertible Debentures for the quarter ended 30th June, 2026.
Astec Lifesciences Ltd filed its quarterly shareholding pattern as of June 30, 2026. The filing lists promoters and public shareholders' stakes.
Astec LifeSciences submitted its Annual Secretarial Compliance Report for the financial year ended March 2026. The report details regulatory compliance status and past governance observations.
Astec LifeSciences notified shareholders regarding the mandatory transfer of unclaimed dividends and shares to the IEPF. This routine regulatory compliance follows the seven-year non-claim threshold.